Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

C Simon Herrington

Professor

University of Edinburgh

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Medical Imaging

40%

Obstetrics And Gynecology

80%

Cancer Biology

90%

Ovarian Cancer

80%

Oncology

80%

Biopsy

40%

Gynecologic Oncology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles26

Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.

Article Link

Year:

2025

Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisions

Article Link

Year:

2025

Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma

Article Link

Year:

2025

Antibody drug conjugate targets are highly differentially expressed across the major types of ovarian cancer

Article Link

Year:

2025

Response to letter RE: Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma

Article Link

Year:

2025

Pembrolizumab in Patients With Advanced Clear Cell Gynecological Cancer: A Phase 2 Nonrandomized Clinical Trial.

Article Link

Year:

2025

High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma.

Article Link

Year:

2024

FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgrounds

Article Link

Year:

2024

Whole exome sequencing reveals diverse genomic relatedness between paired concurrent endometrial and ovarian carcinomas

Article Link

Year:

2024

The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype-specific

Article Link

Year:

2024

Ovarian carcinosarcoma is highly aggressive compared to other ovarian cancer histotypes

Article Link

Year:

2024

RFWD3 modulates response to platinum chemotherapy and promotes cancer associated phenotypes in high grade serous ovarian cancer.

Article Link

Year:

2024

Closing the loop – the role of pathologists in digital and computational pathology research

Article Link

Year:

2024

Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma

Article Link

Year:

2024

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.

Article Link

Year:

2024

An overview of the molecular pathology of ovarian carcinomas

Article Link

Year:

2024

Deceptive pattern of cervical stromal invasion from an endometrioid endometrial carcinoma

Article Link

Year:

2023

Debiased ambient vibrations optical coherence elastography to profile cell, organoid and tissue mechanical properties

Article Link

Year:

2023

Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.

Article Link

Year:

2023

Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.

Article Link

Year:

2023

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.

Article Link

Year:

2022

Recent Advances in Pathology: the 2022 Annual Review Issue of The Journal of Pathology

Article Link

Year:

2022

Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma

Article Link

Year:

2022

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Article Link

Year:

2022

Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratification.

Article Link

Year:

2022

Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers

Article Link

Year:

2022

Collaborators15

Charlie Gourley

University of Edinburgh

UNITED KINGDOM

Edward Tobias

University of Glasgow

UNITED KINGDOM

pierre bagnaninchi

University of Edinburgh

UNITED KINGDOM

Austin Miller

Asst Professor of Oncology, Biostatistics and Bioinformatics

Roswell Park Comprehensive Cancer Center

UNITED STATES

Sarah Waters

University of Oxford

UNITED KINGDOM

Hannah Kim

The University of British Columbia

CANADA

Peter Bankhead

Reader

University of Edinburgh

UNITED KINGDOM

Robert L Hollis

University of Edinburgh

UNITED KINGDOM

Christoph Grimm

Medical University of Vienna

AUSTRIA

Yvonne Reinwald

Lecturer

University of Nottingham

UNITED KINGDOM

Daniel Field

CRUK TRACC Clinical Lecturer

University of Edinburgh

UNITED KINGDOM

Nischalan Pillay

Associate Clinical Professor

University College London

UNITED KINGDOM

Philip Coates

Masaryk Memorial Cancer Institute

CZECH REPUBLIC

William Cross

Lecturer

University of Westminster

UNITED KINGDOM

Feras Abu Saadeh

Clinical Associate Professor

Trinity College Dublin

IRELAND

How do I reach out?

Meet Kite AI